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The gene trap approach developed for this study allows the generation of an allelic series of Cop1. (A) The structure of the pGT01xf gene 
trap vector along with the structures of the wild-type, trapped (assimilated to a null allele), and hypomorphic alleles. The hypomorphic allele 
is generated by Cre-mediated conversion of the trapped allele. Exons are indicated by black boxes. En2 intr1, intron 1 of Engrailed2; βgeo, 
lacz/neomycin reporter/selection cassette. (B) A representative PCR analysis of E9.5 embryos with the indicated genotypes (left panel). The 
3 primers used are described in Methods. Discrimination of the wild-type, null, and hypomorphic alleles by PCR using 2 different primer sets 
(right panel). (C) Wild-type (+/+ or +/–), homozygous trapped Cop1–/– (–/–), and heterozygous embryos harboring one hypomorphic and one 
trapped allele (h/–) at E10.5 and E14.5, respectively. Control (+/–) mice and mice homozygous for the hypomorphic mutation at P21. Scale 
bars (left to right): 1 mm, 5 mm, and 3 cm. (D) Total lysates were prepared from E9.5 embryos with the indicated genotypes. Cop1 and vinculin 
were detected by Western blotting. The relative amount of Cop1 in the various protein lysates is indicated as percentage relative to the amount 
in wild-type mice (+/+; 100%).
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Cop1 regulates c-Jun protein stability in vivo. (A–C) Cop1 disruption causes a dramatic increase in c-Jun protein levels in vivo. (A) Total 
lysates were prepared from E9.5 embryos with the indicated Cop1 genotypes. c-Jun and vinculin (Vinc) were detected by Western blotting. (B) 
Immunohistochemistry for c-Jun on parasagittal sections from E9.5 Cop1+/– and Cop1–/– embryos. Scale bar (left panels): 1 mm. Original mag-
nification (right panels), ×10. (C) Total lysates were prepared from MEFs, fetal liver cells, and heart of mice with the indicated Cop1 genotypes. 
c-Jun, Cop1, and vinculin were detected by Western blotting. (D) Determination of c-Jun half-life in early-passage MEFs. MEFs were metaboli-
cally pulse labeled using [35S]methionine for 2 hours, and protein extracts were subsequently prepared at the indicated time points. Endogenous 
c-Jun was immunoprecipitated from these extracts and analyzed by Western blotting. The c-Jun signal was quantified and normalized to a stable 
and aspecific protein (*). (E) Cells with the indicated Cop1 genotypes were transduced with empty lentivirus (E) or lentivirus encoding full-length 
(FL) Cop1, a Cop1 deletion mutant lacking its WD40 domain (WD), and a Cop1 RING finger mutant (R). Samples were analyzed by Western 
blotting for protein expression as indicated. Vinculin served as loading control.
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Cop1 modulates AP-1 activity in vivo. (A–C) MEFs were exposed to 30 J/m2 irradiation. (A) Comparison of AP-1–dependent luciferase activity in 
Cop1+/+ and Cop1hypo/– MEFs. The data represent the mean ± SD of 3 independent experiments. (B) Samples were analyzed by Western blotting. 
(C) Transcriptional analysis of c-Jun target genes by Q-RT-PCR analyses. The data were normalized to the level of expression in nontreated 
control, which is set to 1. The data represent the mean ± SD of 3 independent experiments. (D) Western blot analysis of early-passage MEFs. (E) 
Transcriptional analysis of c-Jun target genes by Q-RT-PCR analyses in p53-deficient MEFs. The data were normalized to the level of expres-
sion in control MEFs, which is set to 1. The data represent the mean ± SD of 2 independent experiments. (F) Comparison of AP-1–dependent 
luciferase activity in different organs from P6 Cop1hypo/+ and Cop1hypo/hypo mice. The data were first normalized to the total protein levels and then 
to the luciferase activity observed in Cop1hypo/+ mice, which is set to 1. The data represent the mean ± SD of 4 independent biological replicates. 
(G) Comparison of AP-1–dependent luciferase activity in skin from P6 Cop1hypo/+ and Cop1hypo/hypo mice exposed to UV-B irradiation (750 mJ/cm2). 
The data were normalized first to the total protein levels and then to the luciferase activity observed in Cop1hypo/+ mice, which is set to 1. The data 
represent the mean ± SD of 4 independent biological replicates. (H) Immunohistochemistry for phosphorylated (Ser63) c-Jun on skin sections from 
P6 Cop1+/+ and Cop1hypo/hypo mice. Mice were either nontreated (NT) or exposed to UV-B irradiation. Original magnification, ×20.
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All of these observations are in sharp contrast to what is seen in cells 
deficient for Mdmx and/or Mdm2 (31, 34).

































































































































Cop1 deficiency stimulates cell proliferation in a c-Jun–dependent manner. (A–H) All experiments described were performed with cells lacking 
p53. (A) Growth curve of Cop1+/+ and Cop1hypo/– MEFs; cells were seeded in triplicate at 2 × 105 cells/60-mm dish. The numbers refer to the 
mean values ± SD of 2 independent MEF cultures. (B) Growth curves of MEFs infected with recombinant retroviruses (pBABE) encoding c-Jun 
or puromycin resistance only. Cells were seeded in triplicate at 2 × 105 cells/60-mm dish. The numbers refer to the mean values ± SD of 2 inde-
pendently infected MEF cultures. (C) Samples from B were analyzed by Western blotting. (D) Growth curves of cells expressing shRNAmir–c-Jun 
(shJun) or shRNAmir-scramble (Ctr). Cells were seeded in triplicate at 2 × 105 cells/60-mm dish. The numbers refer to the mean values ± SD of 
2 independently infected MEF cultures. (E) Colony assays were performed with cells expressing shRNAmir–c-Jun or shRNAmir-scramble (Ctr). 
Data are presented relative to the number of colonies obtained in the Cop1hypo/– cultures infected with the control shRNA, which is set to 1. The 
numbers refer to the mean values ± SD of 2 independently infected MEF cultures. (F) Samples from D and E were analyzed by Western blotting. 
(G) Growth curve of Cop1+/+ and Cop1hypo/– MEFs exposed to 10 μM SP600125; cells were seeded in triplicate at 105 cells/100-mm dish. The 
numbers refer to the mean values ± SD of 2 independent MEF cultures. (H) Colony assays using cells from A, B, and G.
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Cop1hypo/hypo mice are tumor prone. (A–C) Spontaneous tumor for-
mation in Cop1hypo/hypo mice. (A) 50% of Cop1hypo/hypo mice analyzed 
(n = 22) by histopathological examination spontaneously developed 
tumors in their first year of life. None of the Cop1hypo/+ control littermates 
analyzed (n = 10) showed hyperplasia or tumor development during 
the course of the experiment (P = 0.036). (B) Most Cop1hypo/hypo mice 
developed T cell lymphoma. Thymi from Cop1hypo/+ and Cop1hypo/hypo 
littermates at 20 weeks; the thymus of the Cop1hypo/hypo mouse is 
tumorous. (C) Left panels: H&E staining of sections of organs from a 
Cop1hypo/hypo mouse that developed lymphoma (lymphoid infiltrates are 
indicated by the arrows). Right panels: Immunohistochemistry for CD3 
on selected organs from Cop1hypo/+ and Cop1hypo/hypo mice; a dramatic 
increase in CD3+ cells in Cop1hypo/hypo tissues supports a T cell origin 
of the infiltrates (arrows). Original magnification, ×14. (D and E) Cop1 
deficiency leads to increased infiltration of CD3+ cells and tumorigene-
sis following exposure to a single sublethal dose (4 Gy) of ionizing radi-
ation. (D) Survival following 4 Gy of whole body irradiation decreased 
in the Cop1hypo/hypo group (n = 28) at 14–32 weeks following irradiation 
in comparison with the group of control Cop1hypo/+ littermates (n = 26) 
(Kaplan-Meier log-rank analysis, P = 0.0002). (E) H&E staining of sec-
tions of several organs from a Cop1hypo/+ control and a Cop1hypo/hypo 
mouse that had developed lymphoma. Immunohistochemistry on sev-
eral organs from Cop1hypo/hypo mouse shows a dramatic increase in 
the number of CD3+ cells, suggesting a T cell origin of the infiltrates 
(see arrows). Original magnification, ×14. (F) Immunohistochemistry 
on several organs shows high levels of phosphorylated (Ser63) c-Jun 
in the infiltrates of Cop1hypo/hypo mouse. Original magnification, ×40.
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Inverse correlation between COP1 and c-JUN protein 
levels in human prostate cancers. (A) COP1 gene-centric 
expression analysis as revealed by Oncomine. COP1 is 
significantly underexpressed in a subset of prostate can-
cers relative to normal prostate tissue (P = 0.001). The 
y axis represents normalized expression units. Box-and-
whisker plots indicate median values of the data and 25th 
and 75th percentiles of the data sets. Whiskers indicate 
minimum and maximum data values that are not outliers. 
P value was calculated by using the Student’s t test. The 
number of samples (n) in each class is indicated. (B) West-
ern blot analysis of COP1 and c-JUN in several prostate 
cancer cell lines. COP1 expression is lost in PC3 cells. 
γ-Tubulin (γ-TUB) served as loading control. (C) Detec-
tion by Western blotting of c-JUN and COP1 in PC3 and 
LNCaP cells treated with the proteasome inhibitor MG-132 
for 2, 4, or 6 hours before lysis. γ-Tubulin served as loading 
control. (D) PC3 cells were transfected with FLAG-tagged 
expression vectors for COP1. COP1 expression in LNCaP 
cells was knocked down by siRNA. Western blot analy-
sis confirmed ectopic and knockdown COP1 expression. 
An inverse correlation between COP1 and c-JUN protein 
levels was observed. γ-Tubulin served as loading control. 
(E) Growth curve of PC3 cells transfected with FLAG-
tagged empty and COP1 expression vectors; cells were 
seeded in triplicate at 1.5 × 105 cells/60-mm dish. The 
numbers refer to the mean values ± SD of 3 independent 
transfection experiments.
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(Invitrogen),  and 100 U/ml penicillin  and 100 mg/ml  streptomycin. 
PC3 cells were transfected with FUGENE HD (Roche). ON-TARGET-
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